Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy

Assessment of low-grade glioma treatment response remains as much of a challenge as the treatment itself. Proton magnetic resonance spectroscopy ((1)H-MRS) and imaging were incorporated into a study of patients receiving temozolomide therapy for low-grade glioma in order to evaluate and monitor tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, P S, Viviers, L, Abson, C, Rowland, I J, Brada, M, Leach, M O, Dzik-Jurasz, A S K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410174/
https://www.ncbi.nlm.nih.gov/pubmed/14970853
http://dx.doi.org/10.1038/sj.bjc.6601593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410174/
https://www.ncbi.nlm.nih.gov/pubmed/14970853
http://dx.doi.org/10.1038/sj.bjc.6601593

Ejemplares similares